Clinical Trials Browser

Unknown × Interventional × Solid Tumor × Clear all

NCT04984668 2024-02-09

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05576961 2024-01-23

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05490264 2023-12-07

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05322512 2023-11-29

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT04911907 2023-11-08

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT06116240 2023-11-03

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT06022276 2023-09-01

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT06022289 2023-09-01

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT06015269 2023-08-29

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04965220 2023-08-09

HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05941936 2023-07-12

A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05940181 2023-07-11

A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05934539 2023-07-07

ALG.APV-527 First-in-human Study

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05821595 2023-06-27

JYB1907 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05869240 2023-06-06

BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05207787 2023-06-01

Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT03781219 2023-05-31

A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05359354 2023-05-16

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT03364400 2023-05-15

Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05833984 2023-04-27

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Phase 1/2 Unknown

LymphoidOther solid neoplasm

Solid Tumor

NCT04542863 2023-03-29

The Molecular Imaging Research of F-18 Labeled DX600 PET Probe

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT04214717 2023-03-28

DC-CIK

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT04214730 2023-03-28

NK

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05748938 2023-03-01

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT05745454 2023-02-27

A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT04930354 2023-02-16

ECP-1014 Treatment for Patients With Solid Tumor Cancers

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05724732 2023-02-13

Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05638828 2022-12-06

A Study of RD14-01 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05373147 2022-10-26

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05528406 2022-09-06

A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT05512780 2022-08-23

Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT05228600 2022-05-20

YL-13027 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05380986 2022-05-19

Camrelizumab Combined With Apatinib Mesylate

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05369286 2022-05-11

A Study to Evaluate the Safety and Efficacy of Max-40279 and Toripalimab in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05360368 2022-05-05

HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04407897 2022-04-28

SOFT

Phase NA Unknown

Other solid neoplasm

Solid Tumor

NCT05284968 2022-03-17

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor

NCT05274191 2022-03-10

An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT05136937 2022-01-31

A Clinical Study of Intratumoral Administration of RT-01 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05212987 2022-01-28

Study of FCN-098 in Patients With Advanced Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04122339 2022-01-19

MAX-10181 Given Orally to Patients With Advanced Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04183764 2022-01-19

MAX-40279-01 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05196360 2022-01-19

PD-L1

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05046847 2021-12-03

A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT05097781 2021-10-28

Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT04802980 2021-07-28

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04866485 2021-04-29

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04832204 2021-04-05

Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases

Phase 2 Unknown

Other solid neoplasm

Solid Tumor

NCT04673396 2020-12-21

Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT04569916 2020-09-30

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

Phase 2 Unknown

Other solid neoplasm

Solid Tumor